v3.25.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Feb. 28, 2023
Balance, shares at Feb. 28, 2023      
Issuance of common stock $ 90 90
Issuance of common stock, shares 9,000,000      
Retroactive application of recapitalization $ 4,052 (4,052)
Retroactive application of recapitalization, shares 32,420,154      
Balance at Mar. 15, 2023 $ 4,142 (4,052) 90
Balance, shares at Mar. 15, 2023 41,420,154      
Stock based compensation (Note 8) 58,536 58,536
Transfer from early exercised stock liability on vesting 200 200
Issuance of common stock related to early exercised stock options
Issuance of common stock related to early exercised stock options, shares 2,278,108      
Repurchase of unvested early exercise stock options
Repurchase of unvested early exercise stock options, shares (920,448)      
Repurchase of common stock $ (119) 116 (3)
Repurchase of common stock, shares (1,278,042)      
Net loss (3,793,585) (3,793,585)
Balance at Dec. 31, 2023 $ 4,023 54,800 (3,793,585) (3,734,762)
Balance, shares at Dec. 31, 2023 41,499,772      
Balance at Nov. 30, 2023 $ 87 58,736 (3,793,585) (3,734,762)
Balance, shares at Nov. 30, 2023 9,017,300      
Retroactive application of recapitalization $ 3,936 (3,936)
Retroactive application of recapitalization, shares 32,482,472      
Balance at Dec. 31, 2023 $ 4,023 54,800 (3,793,585) (3,734,762)
Balance, shares at Dec. 31, 2023 41,499,772      
Issuance of common stock $ 6 268,992 268,998
Issuance of common stock, shares 55,826      
Stock based compensation (Note 8) 9,750,511 9,750,511
Transfer from early exercised stock liability on vesting 30 2,325 2,355
Repurchase of unvested early exercise stock options
Repurchase of unvested early exercise stock options, shares (255,686)      
Net loss (23,753,863) (23,753,863)
Synthetic at-the-market (“ATM”) commitment fee $ 6 499,994 500,000
Synthetic at the market ATM commitment fee, shares 63,694      
Shares issued upon exercise of common stock warrants $ 13 1,626,606 1,626,619
Shares issued upon exercise of common stock warrants, shares 135,796      
Shares issued upon conversion of SAFE notes 64 6,367,136 6,367,200
Shares issued upon conversion of SAFE notes, shares 636,916      
Shares issued upon conversion of convertible notes $ 26 2,571,374 2,571,400
Shares issued upon conversion of convertible notes, shares 257,216      
Issuance of common stock upon the reverse capitalization including PIPE financing, net of transaction costs $ 435 (5,483,454) (5,483,019)
Issuance of common stock upon the reverse capitalization including PIPE financing, net of transaction costs, shares 5,342,745      
Transaction costs (7,501,223) (7,501,223)
Merger Earnout shares (Note 3) 25,071,500 (25,071,500)
Balance at Dec. 31, 2024 $ 4,603 $ 33,228,561 $ (52,618,948) $ (19,385,784)
Balance, shares at Dec. 31, 2024 47,736,279